138 related articles for article (PubMed ID: 9721347)
1. [Antibody radiolabeling with technetium-99m].
Perera A; Pérez C
Rev Esp Med Nucl; 1998; 17(4):302-9. PubMed ID: 9721347
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of reduction-mediated labelling of antibodies with technetium-99m.
Zhang ZM; Ballinger JR; Sheldon K; Boxen I
Int J Rad Appl Instrum B; 1992 Aug; 19(6):607-9. PubMed ID: 1522015
[TBL] [Abstract][Full Text] [Related]
3. Development of radiochemically pure antibodies.
Eckelman WC
Cancer Res; 1990 Feb; 50(3 Suppl):780s-782s. PubMed ID: 2297723
[TBL] [Abstract][Full Text] [Related]
4. Investigations of directly labeling antibodies with rhenium-188.
Winnard P; Virzi E; Fogarasi M; Rusckowski M; Hnatowich DJ
Q J Nucl Med; 1996 Jun; 40(2):151-60. PubMed ID: 8909100
[TBL] [Abstract][Full Text] [Related]
5. Fast and specific labeling of antibody fragments with multiple atoms of heavy metal radioisotopes.
Trubetskoy VS; Torchilin VP
Anal Biochem; 1995 Aug; 229(2):345-7. PubMed ID: 7485993
[No Abstract] [Full Text] [Related]
6. Evaluation of formamidine sulfinic acid and other reducing agents for use in the preparation of Tc-99m labeled radiopharmaceuticals.
Fritzberg AR; Lyster DM; Dolphin DH
J Nucl Med; 1977 Jun; 18(6):553-7. PubMed ID: 192859
[TBL] [Abstract][Full Text] [Related]
7. Investigations of ascorbate for direct labeling of antibodies with technetium-99m.
Hnatowich DJ; Virzi F; Winnard P; Fogarasi M; Rusckowski M
J Nucl Med; 1994 Jan; 35(1):127-34. PubMed ID: 8271033
[TBL] [Abstract][Full Text] [Related]
8. Radiolabeling of affinity-purified goat anti-carcinoembryonic antigen immunoglobulin G with technetium-99m.
Pettit WA; DeLand FH; Bennett SJ; Goldenberg DM
Cancer Res; 1980 Aug; 40(8 Pt 2):3043-5. PubMed ID: 7397698
[TBL] [Abstract][Full Text] [Related]
9. Reduction-mediated technetium-99m labeling of monoclonal antibodies.
Mather SJ; Ellison D
J Nucl Med; 1990 May; 31(5):692-7. PubMed ID: 2341907
[TBL] [Abstract][Full Text] [Related]
10. Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex.
Waibel R; Alberto R; Willuda J; Finnern R; Schibli R; Stichelberger A; Egli A; Abram U; Mach JP; Plückthun A; Schubiger PA
Nat Biotechnol; 1999 Sep; 17(9):897-901. PubMed ID: 10471933
[TBL] [Abstract][Full Text] [Related]
11. Simplified preformed chelate protein radiolabeling with technetium-99m mercaptoacetamidoadipoylglycylglycine (N3S-adipate).
Kasina S; Sanderson JA; Fitzner JN; Srinivasan A; Rao TN; Hobson LJ; Reno JM; Axworthy DB; Beaumier PL; Fritzberg AR
Bioconjug Chem; 1998; 9(1):108-17. PubMed ID: 9460553
[TBL] [Abstract][Full Text] [Related]
12. A new method for labelling of monoclonal antibodies and their fragments with technetium-99m.
Joiris E; Bastin B; Thornback JR
Int J Rad Appl Instrum B; 1991; 18(3):353-6. PubMed ID: 2071447
[TBL] [Abstract][Full Text] [Related]
13. Influence of tobacco on the labelling of red blood cells and plasma proteins with technetium-99m.
Vidal MV; Gutfilen B; da Fonseca LM; Bernardo-Filho M
J Exp Clin Cancer Res; 1998 Mar; 17(1):41-6. PubMed ID: 9646232
[TBL] [Abstract][Full Text] [Related]
14. Efficient one-step direct labelling of recombinant antibodies with technetium-99m.
Liberatore M; Neri D; Neri G; Pini A; Iurilli AP; Ponzo F; Spampinato G; Padula F; Pala A; Colella AC
Eur J Nucl Med; 1995 Nov; 22(11):1326-9. PubMed ID: 8575486
[TBL] [Abstract][Full Text] [Related]
15. Radiolabeled antibodies specific for human blood elements.
Thakur ML; DeFulvio J
Prog Clin Biol Res; 1990; 355():281-92. PubMed ID: 2281107
[No Abstract] [Full Text] [Related]
16. Radiolabeling of antibodies.
Eckelman WC; Paik CH; Reba RC
Cancer Res; 1980 Aug; 40(8 Pt 2):3036-42. PubMed ID: 7397697
[TBL] [Abstract][Full Text] [Related]
17. Ascorbate plays a major role in labeling proteins with technetium-99m.
Thakur ML
J Nucl Med; 1994 Sep; 35(9):1566-8. PubMed ID: 8071714
[No Abstract] [Full Text] [Related]
18. Improved protein labeling by stannous tartrate reduction of pertechnetate.
Pettit WA; DeLand FH; Bennett SJ; Goldenberg DM
J Nucl Med; 1980 Jan; 21(1):59-62. PubMed ID: 7356741
[TBL] [Abstract][Full Text] [Related]
19. Current use and future potential of organometallic radiopharmaceuticals.
Schibli R; Schubiger PA
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1529-42. PubMed ID: 12397472
[TBL] [Abstract][Full Text] [Related]
20. The chemical state of 99m Tc in biomedical products. II. The chelation of reduced technetium with DTPA.
Eckelman WC; Meinken G; Richards P
J Nucl Med; 1972 Aug; 13(8):577-81. PubMed ID: 5041632
[No Abstract] [Full Text] [Related]
[Next] [New Search]
